N-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide

C21H20N8O5 — CID 118496299

IUPACN-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide
SMILESCC1(C(O)C(=O)Nc2ccc3c(N)noc3c2)OCCN(c2ccn(-c3ccnnc3)n2)C1=O
InChIInChI=1S/C21H20N8O5/c1-21(17(30)19(31)25-12-2-3-14-15(10-12)34-27-18(14)22)20(32)28(8-9-33-21)16-5-7-29(26-16)13-4-6-23-24-11-13/h2-7,10-11,17,30H,8-9H2,1H3,(H2,22,27)(H,25,31)
InChIKeyHAOURTPHXXIGQA-UHFFFAOYSA-N
MW464.44 g/mol
LogP0.51
Rot. Bonds5

About N-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide

N-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide (PubChem CID 118496299) has the molecular formula C21H20N8O5 and a molecular weight of 464.44 g/mol. Its IUPAC name is N-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide.

Molecular Properties

Compound NameN-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide
PubChem CID118496299
Molecular FormulaC21H20N8O5
Molecular Weight464.44 g/mol
Exact Mass464.16
IUPAC NameN-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide
SMILESCC1(C(O)C(=O)Nc2ccc3c(N)noc3c2)OCCN(c2ccn(-c3ccnnc3)n2)C1=O
InChIInChI=1S/C21H20N8O5/c1-21(17(30)19(31)25-12-2-3-14-15(10-12)34-27-18(14)22)20(32)28(8-9-33-21)16-5-7-29(26-16)13-4-6-23-24-11-13/h2-7,10-11,17,30H,8-9H2,1H3,(H2,22,27)(H,25,31)
InChIKeyHAOURTPHXXIGQA-UHFFFAOYSA-N
XLogP0.51
TPSA174.52 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds5
Heavy Atoms34
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500464.44
LogP ≤ 50.51
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Analyze N-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide?
The IUPAC name of N-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide (CID 118496299) is N-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide.
What is the SMILES notation for N-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide?
The canonical SMILES for N-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide is CC1(C(O)C(=O)Nc2ccc3c(N)noc3c2)OCCN(c2ccn(-c3ccnnc3)n2)C1=O.
What is the InChIKey of N-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide?
The InChIKey is HAOURTPHXXIGQA-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H20N8O5/c1-21(17(30)19(31)25-12-2-3-14-15(10-12)34-27-18(14)22)20(32)28(8-9-33-21)16-5-7-29(26-16)13-4-6-23-24-11-13/h2-7,10-11,17,30H,8-9H2,1H3,(H2,22,27)(H,25,31).
What are the key properties of N-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide?
N-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide has a molecular weight of 464.44 g/mol, XLogP of 0.51, 5 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-(3-amino-1,2-benzoxazol-6-yl)-2-hydroxy-2-[2-methyl-3-oxo-4-(1-pyridazin-4-ylpyrazol-3-yl)morpholin-2-yl]acetamide is sourced from PubChem (CID 118496299), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).